Literature DB >> 22932121

Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction.

Ae S Lee1, Jung E Lee, Yu J Jung, Duk H Kim, Kyung P Kang, Sik Lee, Sung K Park, Sang Y Lee, Myung J Kang, Woo S Moon, Hyung J Kim, Young B Jeong, Mi J Sung, Won Kim.   

Abstract

Lymphatic remodeling in inflammation has been found in tracheal mycoplasma infection, human kidney transplant, skin inflammation, peritonitis, and corneal inflammation. Here we investigated lymphangiogenesis in fibrotic area in unilateral ureteral obstruction, a model of progressive renal fibrosis, and evaluated the roles of vascular endothelial growth factor (VEGF)-C and -D in the obstructed kidney. Compared to sham-operated mice, the number of LYVE-1-positive lymphatic vessels, the proliferation of LYVE-1-positive lymphatic endothelial cells, along with VEGF-C and -D mRNA expression were all significantly increased following ureteral obstruction. Depletion of macrophages with clodronate decreased lymphangiogenesis in the obstructed kidney. VEGF-C expression was higher in M2- than in M1-polarized macrophages from bone marrow-derived macrophages, and also increased in Raw 264.7 or renal proximal tubule cells by stimulation with TGF-β1 or TNF-α. VEGF-D reversed the inhibitory effect of TGF-β1 on VEGF-C-induced migration, capillary-like tube formation, and proliferation of human lymphatic endothelial cells. Additionally, the blockade of VEGF-C and VEGF-D signaling decreased obstruction-induced lymphangiogenesis. Thus, VEGF-C and VEGF-D are associated with lymphangiogenesis in the fibrotic kidney in a mouse model of ureteral obstruction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22932121     DOI: 10.1038/ki.2012.312

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

1.  Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction.

Authors:  Shoko Hasegawa; Toshiaki Nakano; Kumiko Torisu; Akihiro Tsuchimoto; Masahiro Eriguchi; Naoki Haruyama; Kosuke Masutani; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Lab Invest       Date:  2017-10-30       Impact factor: 5.662

2.  Augmenting Renal Lymphatic Density Prevents Angiotensin II-Induced Hypertension in Male and Female Mice.

Authors:  Dakshnapriya Balasubbramanian; Catalina A Lopez Gelston; Alexandra H Lopez; Geina Iskander; Winter Tate; Haley Holderness; Joseph M Rutkowski; Brett M Mitchell
Journal:  Am J Hypertens       Date:  2020-01-01       Impact factor: 2.689

3.  Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.

Authors:  Jiaqi Mi; Erika Hooker; Steven Balog; Hong Zeng; Daniel T Johnson; Yongfeng He; Eun-Jeong Yu; Huiqing Wu; Vien Le; Dong-Hoon Lee; Joseph Aldahl; Mark L Gonzalgo; Zijie Sun
Journal:  J Biol Chem       Date:  2018-11-06       Impact factor: 5.157

Review 4.  Immune cell trafficking, lymphatics and hypertension.

Authors:  Dakshnapriya Balasubbramanian; Catalina A Lopez Gelston; Joseph M Rutkowski; Brett M Mitchell
Journal:  Br J Pharmacol       Date:  2018-06-25       Impact factor: 8.739

5.  Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.

Authors:  Yuanjian Chen; Wenyuan Zhao; Chang Liu; Weixin Meng; Tieqiang Zhao; Syamal K Bhattacharya; Yao Sun
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

Review 6.  Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire?

Authors:  Gabriella R Abouelkheir; Bradley D Upchurch; Joseph M Rutkowski
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-07

7.  SIRT2 Regulates LPS-Induced Renal Tubular CXCL2 and CCL2 Expression.

Authors:  Yu Jin Jung; Ae Sin Lee; Tung Nguyen-Thanh; Dal Kim; Kyung Pyo Kang; Sik Lee; Sung Kwang Park; Won Kim
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

8.  Effect of FIGF overexpression on liver cells transforming to insulin-producing cells.

Authors:  Yaqin He; Xiaoliang Xie; Xiaoyan Li; Shikuo Rong; Yukui Li; Zhenhui Lu
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

Review 9.  Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases.

Authors:  Daniyal J Jafree; David A Long
Journal:  J Am Soc Nephrol       Date:  2020-04-15       Impact factor: 10.121

Review 10.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.